News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Staff September 11, 2023 Iframe sync Post navigation Previous: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNext: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors More Stories News Patient Care RazorMetrics Named to Deloitte Technology Fast 500 for Second Consecutive Year Staff November 18, 2026 Apps EHR Healthcare News Nursing DocLinq launched to Tackle Fragmented U.S. Healthcare System by simultaneously empowering Patients & Healthcare Providers Staff November 18, 2026 Healthcare News Medline launches right-sized Ranpak packaging solutions in two key distribution centers Staff November 18, 2026